Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

(2023) Ferenc E Mózes et al.   Lancet Gastroenterology & Hepatology

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

(2021) Ferenc Emil Mózes et al.   GUT

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update

(2021) Annalisa Berzigotti et al.   JOURNAL OF HEPATOLOGY

Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories

(2020) Stefano Ciardullo et al.   HYPERTENSION

Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005–2016

(2019) Donghee Kim et al.   Hepatology International

Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States

(2019) Pegah Golabi et al.   BMC GASTROENTEROLOGY

Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis

(2019) Brooke Levis et al.   BMJ-British Medical Journal

Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease

(2019) Salvatore Petta et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes

(2019) Fernando Bril et al.   DIABETES CARE

Using the 9-Item Patient Health Questionnaire to Screen for and Monitor Depression

(2019) Mark Zimmerman   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

More Evidence for the Genetic Susceptibility of Mexicans Population to Nonalcoholic Fatty Liver Disease through PNPLA3

(2018) Paulina Chinchilla-López et al.   Annals of Hepatology

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers

(2018) Eduardo Vilar-Gomez et al.   JOURNAL OF HEPATOLOGY

Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease

(2018) Luis C. Bertot et al.   LIVER INTERNATIONAL

Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)

(2018) Pegah Golabi et al.   MEDICINE

Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis

(2017) Guangqin Xiao et al.   HEPATOLOGY

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

(2017) Hannes Hagström et al.   JOURNAL OF HEPATOLOGY

Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease

(2017) Sae Kyung Joo et al.   LIVER INTERNATIONAL

Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States

(2017) Michael H. Le et al.   PLoS One

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

(2016) Stuart McPherson et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort

(2016) Veronica Wendy Setiawan et al.   HEPATOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: A meta-analysis study

(2016) Wenjing Sun et al.   HEPATOLOGY RESEARCH

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk

(2015) Ehimen C. Aneni et al.   JOURNAL OF HYPERTENSION

Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey

(2014) C. E. Ruhl et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Development, External Validation and Comparative Assessment of a New Diagnostic Score for Hepatic Steatosis

(2014) Peter J Meffert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals

(2014) Daniel J Cuthbertson et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Non–Laboratory-Based Self-Assessment Screening Score for Non-Alcoholic Fatty Liver Disease: Development, Validation and Comparison with Other Scores

(2014) Yong-ho Lee et al.   PLoS One

NAFLD prevalence differs among hispanic subgroups: The multi-ethnic study of atherosclerosis

(2014) Michael Wayne Fleischman   WORLD JOURNAL OF GASTROENTEROLOGY

Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994

(2013) Mariana Lazo et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study

(2013) Edith M. Koehler et al.   Clinical Gastroenterology and Hepatology

Association Between Variants in or Near PNPLA3, GCKR, and PPP1R3B With Ultrasound-Defined Steatosis Based on Data From the Third National Health and Nutrition Examination Survey

(2013) Ruben Hernaez et al.   Clinical Gastroenterology and Hepatology

Noninvasive evaluation of NAFLD

(2013) Laurent Castera et al.   Nature Reviews Gastroenterology & Hepatology

The global NAFLD epidemic

(2013) Rohit Loomba et al.   Nature Reviews Gastroenterology & Hepatology

Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal

(2012) Mariana V. Machado et al.   JOURNAL OF HEPATOLOGY

Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008

(2011) Zobair M. Younossi et al.   Clinical Gastroenterology and Hepatology

Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase

(2011) Alejandro López-Suárez et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

(2010) Giovanni Musso et al.   ANNALS OF MEDICINE

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology